Area of research
Animal Science and Zoology · Molecular Biology
Research interest
Research topics from publications: GBP2 facilitates the progression of glioma via regulation of KIF22/EGFR signaling; GBP2 as a potential prognostic predictor with immune-related characteristics in glioma; Integrated bioinformatics analysis and experimental validation identified CDCA families as prognostic biomarkers and sensitive indicators for rapamycin treatment of glioma; Endothelial Progenitor Cells Correlated with Oxidative Stress after Mild Traumatic Brain Injury; The value of basement membrane-associated genes in the prognosis and immune regulation of glioma. Representative work: Identifying the mechanism of glioma progression is critical for diagnosis and treatment. Although studies have shown that guanylate-binding protein 2(GBP2) has critical roles in various cancers, its function in glioma is unclear. In this work, we demonstrate that GBP2 has high expression levels in glioma tissues. In glioma cells, depletion of GBP2 impairs proliferation and migration, whereas overexpression of GBP2 enhances proliferation and migration. Regarding the mechanism, we clarify that epidermal growth factor receptor (EGFR) signaling is regulated by GBP2, and also demonstrate that GBP2 interacts directly with kinesin family member 22(KIF22) and regulates glioma progression through KIF Guanylate binding protein 2 (GBP2) is a member of the guanine binding protein family, and its relationship with prognostic outcomes and tumor immune microenvironments in glioma remains elusive. We found GBP2 were increased in glioma tissues at both mRNA and protein levels. Kaplan-Meier curves revealed that high GBP2 expression was linked with worse survival of glioma patients, and multivariate Cox regression analysis indicated that high GBP2 expression was an independent prognostic factor for glioma. Combined analysis in immune database revealed that the expression of GBP2 was significantly related to the level of immune infiltration and immunomodulators. Single-cell analysis illustrated the
Integrated bioinformatics analysis and experimental validation identified CDCA families as prognostic biomarkers and sensitive indicators for rapamycin treatment of glioma
The value of basement membrane-associated genes in the prognosis and immune regulation of glioma
GBP2 facilitates the progression of glioma via regulation of KIF22/EGFR signaling
GBP2 as a potential prognostic predictor with immune-related characteristics in glioma
Endothelial Progenitor Cells Correlated with Oxidative Stress after Mild Traumatic Brain Injury